Blog

Learn how blended genome–exome sequencing delivers integrated genomic insight for liver disease, pancreatitis, and broader precision-medicine applications

Discover how Eremid’s CAP/CLIA-certified services with BioSkryb ResolveOME and ResolveSEQ LongRead unlock single-cell multiomics at scale.

Discover how BGE sequencing blends genome-wide breadth with exome depth for scalable, cost-effective variant detection across research and clinical projects.

DNA methylation plays a critical role in cancer progression, influencing tumor suppressor gene silencing, oncogene activation, and therapy resistance. While next-generation sequencing (NGS) has expanded our understanding of epigenetics, traditional short-read approaches like bisulfite sequencing face significant limitations—particularly in complex and repetitive genomic regions.

Explore the world of the human microbiome. Discover how genomics is revealing the mysteries of the microbiome, informing the personalized therapies of tomorrow.

Explore how cancer genomics is transforming oncology and enabling personalized treatments.

Explore the exposome, how it interacts with our genes to shape health and disease and how omics technologies are enabling deeper insights into environmental risks.

Discover how the latest human genome embraces humanity’s natural diversity and, thereby, enhances clinical research into disease and drug discovery.

For the first time, we have a complete sequence of the Y chromosome. Learn why this could have implications for health and longevity.

As we put the COVID-19 pandemic behind us, find out how genomics is helping us learn about the impacts of long COVID, and why it affects some and not others.

Discover how genomics is helping to improve diagnosis and treatment of rare diseases, offering hope to patients.

Have you ever wondered why a particular cold medicine works wonders for your partner but always gives you a headache? This type of variability from person to person is true